Aims and Scope of Journal of Clinical Psychopharmacology
The Journal of Clinical Psychopharmacology is a peer-reviewed medical journal published by Lippincott Williams & Wilkins covering clinical psychopharmacology. It was founded by Richard I. Shader, MD in 1981 as the first journal of an international scope devoted solely to clinical psychopharmacology. David J. Greenblatt, MD served as Co-Editor-In-Chief. Drs. Shader and Greenblatt remained at the helm of the journal until both retired at the end of 2020. Anthony J. Rothschild, MD became JCP’s new Editor-in-Chief in January 2021. Less
Key Metrics
CiteScore 

3.4
Impact Factor 

< 5
SJR 

Q1Medicine (all)

SNIP 

0.86
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Clinical Psychopharmacology
Journal of Clinical Psychopharmacology Journal Specifications
Indexed in the following public directories
Web of Science
SJR
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1981 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Clinical Psychopharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Clinical Psychopharmacology
Pregnancy Outcomes After First-Trimester Exposure to Vortioxetine: Prospective Outcomes From the MGH National Pregnancy Registry for Psychiatric Medications.
- 29 Jun 2026
- Journal of clinical psychopharmacology
Antidepressant-Induced Sexual Dysfunction in Adults: A Targeted Scoping Review and Clinical Update.
- 24 Jun 2026
- Journal of clinical psychopharmacology
Safety of Adjunct Low-Dose Methylphenidate Extended-Release for Cognitive Deficits in Stable Schizophrenia: Results From an Open-Label, Randomized Crossover Trial.
- 18 Jun 2026
- Journal of clinical psychopharmacology
Deciphering Mental Illness: Neurons vs. Neuroglia.
- 17 Jun 2026
- Journal of clinical psychopharmacology
Risk Factors for Delirium in Hospitalized Patients With Medical Conditions Receiving Dual Orexin Receptor Antagonists: A Retrospective Cohort Study.
- 11 Jun 2026
- Journal of clinical psychopharmacology
Article Selected to Receive the Mitchell B. Balter Award for Publications in 2025.
- 11 Jun 2026
- Journal of clinical psychopharmacology
Pregnancy Outcomes After First-Trimester Exposure to Vortioxetine: Prospective Outcomes From the MGH National Pregnancy Registry for Psychiatric Medications.
- 29 Jun 2026
- Journal of clinical psychopharmacology
Antidepressant-Induced Sexual Dysfunction in Adults: A Targeted Scoping Review and Clinical Update.
- 24 Jun 2026
- Journal of clinical psychopharmacology
Safety of Adjunct Low-Dose Methylphenidate Extended-Release for Cognitive Deficits in Stable Schizophrenia: Results From an Open-Label, Randomized Crossover Trial.
- 18 Jun 2026
- Journal of clinical psychopharmacology
Deciphering Mental Illness: Neurons vs. Neuroglia.
- 17 Jun 2026
- Journal of clinical psychopharmacology
Risk Factors for Delirium in Hospitalized Patients With Medical Conditions Receiving Dual Orexin Receptor Antagonists: A Retrospective Cohort Study.
- 11 Jun 2026
- Journal of clinical psychopharmacology
Article Selected to Receive the Mitchell B. Balter Award for Publications in 2025.
- 11 Jun 2026
- Journal of clinical psychopharmacology